- Report
- August 2025
- 180 Pages
Global
From €3139EUR$3,545USD£2,690GBP
€3488EUR$3,939USD£2,989GBP
- Report
- August 2025
- 195 Pages
Global
From €3139EUR$3,545USD£2,690GBP
€3488EUR$3,939USD£2,989GBP
- Report
- August 2025
- 194 Pages
Global
From €3139EUR$3,545USD£2,690GBP
€3488EUR$3,939USD£2,989GBP
- Report
- August 2025
- 192 Pages
Global
From €3139EUR$3,545USD£2,690GBP
€3488EUR$3,939USD£2,989GBP
- Report
- August 2025
- 182 Pages
Global
From €3139EUR$3,545USD£2,690GBP
€3488EUR$3,939USD£2,989GBP
- Report
- July 2025
Global
From €4339EUR$4,900USD£3,718GBP
From €4339EUR$4,900USD£3,718GBP
- Report
- August 2025
- 197 Pages
Global
From €3139EUR$3,545USD£2,690GBP
€3488EUR$3,939USD£2,989GBP
- Report
- March 2024
- 200 Pages
Global
From €3675EUR$4,150USD£3,149GBP
- Report
- October 2023
- 145 Pages
Global
From €2789EUR$3,150USD£2,390GBP
- Report
- October 2023
- 145 Pages
Global
From €2789EUR$3,150USD£2,390GBP
- Report
- October 2023
- 145 Pages
Global
From €2789EUR$3,150USD£2,390GBP
- Report
- December 2022
- 120 Pages
Global
From €3985EUR$4,500USD£3,414GBP
- Report
- August 2025
- 182 Pages
Global
From €3139EUR$3,545USD£2,690GBP
€3488EUR$3,939USD£2,989GBP
- Report
- January 2025
- 82 Pages
Saudi Arabia
From €3099EUR$3,500USD£2,656GBP
- Report
- January 2025
- 82 Pages
Saudi Arabia
From €3099EUR$3,500USD£2,656GBP
- Report
- September 2024
- 181 Pages
Global
From €3985EUR$4,500USD£3,414GBP
- Report
- August 2024
- 82 Pages
Japan
From €3099EUR$3,500USD£2,656GBP
- Report
- May 2024
- 181 Pages
Global
From €3985EUR$4,500USD£3,414GBP
- Report
- October 2023
- 90 Pages
United States
From €3099EUR$3,500USD£2,656GBP

The Dermatologicals market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin diseases, including acne, psoriasis, eczema, and skin cancer. Dermatologicals are typically administered topically, although some may be taken orally. The market is highly competitive, with a wide range of products available from both generic and branded manufacturers.
The Dermatologicals market is driven by the increasing prevalence of skin diseases, as well as the development of new treatments and technologies. Additionally, the increasing demand for cosmetic treatments has also contributed to the growth of the market.
Some of the major companies in the Dermatologicals market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. Other notable players include Allergan, Galderma, and Sun Pharmaceuticals. Show Less Read more